EEF1A2 and cancer: Within the collection of small-sized TMs developed, a scFv-based TM directed against the tumor-associated carbohydrate antigen sialyl-Tn (STn) was proven to efficiently and specifically redirect UniCAR T-cells to STn-expressing cancer cells [12].